Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 118, Issue , 2016, Pages 17-26

  Gregoire M ^a,b   Leroy, A G ^a   Bouquie R ^a,c   Malandain, D ^a   Dailly, E ^a,b   Boutoille, D ^a,b   Renaud, C ^a   Jolliet, P ^a,c   Caillon, J ^a,b   Deslandes, G ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Universite de Nantes   (France)

Author keywords

25 O Desacetylrifampicin; Ceftaroline; Daptomycin; Linezolid; Rifampicin

Indexed keywords

25 O DESACETYLRIFAMPICIN; CEFTAROLINE FOSAMIL; DAPTOMYCIN; DRUG METABOLITE; LINEZOLID; RIFAMPICIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEFTAROLINE; CEPHALOSPORIN DERIVATIVE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; BONE INFECTION; CENTRIFUGATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONIZATION; LIMIT OF QUANTITATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRECIPITATION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SUPERNATANT; TANDEM MASS SPECTROMETRY; BLOOD; PROCEDURES;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPTOMYCIN; HUMANS; LINEZOLID; RIFAMPIN; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84945284584     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2015.10.008     Document Type: Article

References (37)

1. European Centre for Disease Prevention and Control, EARSS Annual Reports.
2. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., Talan D.A. et EMERGEncy ID Net Study Group Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 2006, 355:666-674.
3. Centers for Disease Control and Prevention (CDC) Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan, 1996. MMWR Morb. Mortal. Wkly. Rep. 1997, 626.
4. Acocella G. Clinical pharmacokinetics of rifampicin. Clin. Pharmacokinet. 1978, 12.
5. Safdar N., Andes D., Craig W.A. In vivo pharmacodynamic activity of daptomycin. Antimicrob. Agents Chemother. 2004, 48:63-68.
6. Bhavnani S.M., Rubino C.M., Ambrose P.G., Drusano G.L. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin. Infect. Dis. 2010, 50:1568-1574.
7. Pea F., Viale P., Cojutti P., Del Pin B., Zamparini E., Furlanut M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J. Antimicrob. Chemother. 2012, 67:2034-2042.
8. Rayner C.R., Forrest A., Meagher A.K., Birmingham M.C., Schentag J.J. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin. Pharmacokinet. 2003, 42:1411-1423.
9. Tsuji Y., Hiraki Y., Matsumoto K., Mizoguchi A., Kobayashi T., Sadoh S., Morita K., Kamimura H., Karube Y. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. J. Infect. Chemother. 2011, 17:70-75.
10. Alsultan et A., Peloquin C.A. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs 2014, 854.
11. Bhavnani S.M., Hammel J.P., Van Wart S.A., Rubino C.M., Reynolds D.K., Forrest A., Drusano G.L., Khariton T., Friedland H.D., Riccobene T.A., Ambrose P.G. Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections. Antimicrob. Agents Chemother. 2015, 59:372-380.
12. Roblot F., Besnier J.-M., Giraudeau B., Simonnard N., Jonville-Bera A.-P., Coipeau P., Choutet P., Autret-Leca E., Le Guellec C. Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections. Fundam. Clin. Pharmacol. 2007, 21:363-369.
13. Verdier M.-C., Bentué-Ferrer D., Tribut O., Collet N., Revest M., Bellissant E. Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application. Clin. Chem. Lab. Med. 2011, 49:69-75.
14. Bazoti F.N., Gikas E., Skoutelis A., Tsarbopoulos A. Development and validation of an ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of daptomycin in human plasma. J. Pharm. Biomed. Anal. 2011, 85.
15. Cazorla-Reyes R., Romero-González R., Frenich A.G., Rodríguez Maresca M.A., Martínez Vidal J.L. Simultaneous analysis of antibiotics in biological samples by ultra high performance liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2014, 212.
16. Szultka M., Krzeminski R., Jackowski M., Buszewski B. Simultaneous determination of selected chemotherapeutics in human whole blood by molecularly imprinted polymers coated solid phase microextraction fibers and liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 76.
17. Tsai I.-L., Sun H.-Y., Chen G.-Y., Lin S.-W., Kuo C.-H. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry. Talanta 2013, 603.
18. Jourdil J.-F., Tonini J., Stanke-Labesque F. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 1-9.
19. Szultka M., Krzeminski R., Szeliga J., Jackowski M., Buszewski B. A new approach for antibiotic drugs determination in human plasma by liquid chromatography-mass spectrometry. J. Chromatogr. A 2013, 41-49.
20. Olszowy P., Szultka M., Nowaczyk J., Buszewski B. A new way of solid-phase microextraction fibers preparation for selected antibiotic drug determination by HPLC-MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 2548.
21. Colin P., De Bock L., T'jollyn H., Boussery K., Van Bocxlaer J. Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry. Talanta 2013, 293.
22. Han M., Jun S.H., Lee J.H., Park K.U., Song J., Song S.H. Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS. J. Antimicrob. Chemother. 2013, 68:2066-2073.
23. Zander J., Maier B., Suhr A., Zoller M., Frey L., Teupser D., Vogeser M. Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation. Clin. Chem. Lab. Med. 2014, 53:781-791.
24. Barco S., Bandettini R., Maffia A., Tripodi G., Castagnola E., Cangemi G. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography-tandem mass spectrometry. J. Chemother. 2014.
25. Kim H.-J., Seo K.-A., Kim H.-M., Jeong E.-S., Ghim J.L., Lee S.H., Lee Y.M., Kim D.H., Shin J.-G. Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2015, 16.
26. Hartkoorn R.C., Khoo S., Back D.J., Tjia J.F., Waitt C.J., Chaponda M., Davies G., Ardrey A., Ashleigh S., Ward S.A. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 82.
27. Hee K.H., Seo J.J., Lee L.S. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study. J. Pharm. Biomed. Anal. 2014, 253-260.
28. Srivastava A., Waterhouse D., Ardrey A., Ward S.A. Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic-tandem mass spectrometric method. J. Pharm. Biomed. Anal. 2012, 528.
29. de Velde F., Alffenaar J.-W.C., Wessels A.M.A., Greijdanus B., Uges D.R.A. Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:1771-1777.
30. Song S.H., Jun S.H., Park K.U., Yoon Y., Lee J.H., Kim J.Q., Song J. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography-tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2007, 21:1331-1338.
31. Hee K.H., Yao Z., Lee L.S. Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study. J. Pharm. Biomed. Anal. 2014, 88:584-593.
32. Riccobene T.A., Su S.F., Rank D. Single- and multiple-dose study to determine thes afety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects. Antimicrob. Agents Chemother. 2013, 57:1496-1504.
33. Stein G.E., Yasin F., Smith C., Scharmen A., Havlichek D., et Bill C. A pharmacokinetic-pharmacodynamic analysis of ceftaroline prophylaxis in patients with external ventricular drains. Surg. Infect. (Larchmt) 2015, 16:169-173.
34. U.S. Department of Health and Human Services Food and Drug Administration, Guidance for industry FDA, Bioanalytical Method Validation (2001).
35. European medicines agency, Guideline on bioanalytical method validation. (2012).
36. Comité français d'accréditation SH GTA 04. (2011).
37. Koal T., Deters M., Casetta B., Kaever V. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 222.